Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland : a national prospective cohort study
| dc.contributor.author | Vasileiou, Eleftheria | |
| dc.contributor.author | Simpson, Colin R | |
| dc.contributor.author | Shi, Ting | |
| dc.contributor.author | Kerr, Steven | |
| dc.contributor.author | Agrawal, Utkarsh | |
| dc.contributor.author | Akbari, Ashley | |
| dc.contributor.author | Bedston, Stuart | |
| dc.contributor.author | Beggs, Jillian | |
| dc.contributor.author | Bradley, Declan | |
| dc.contributor.author | Chuter, Antony | |
| dc.contributor.author | de Lusignan, Simon | |
| dc.contributor.author | Docherty, Annemarie B | |
| dc.contributor.author | Ford, David | |
| dc.contributor.author | Hobbs, Fd Richard | |
| dc.contributor.author | Joy, Mark | |
| dc.contributor.author | Katikireddi, Srinivasa Vittal | |
| dc.contributor.author | Marple, James | |
| dc.contributor.author | McCowan, Colin | |
| dc.contributor.author | McGagh, Dylan | |
| dc.contributor.author | McMenamin, Jim | |
| dc.contributor.author | Moore, Emily | |
| dc.contributor.author | Murray, Josephine Lk | |
| dc.contributor.author | Pan, Jiafeng | |
| dc.contributor.author | Ritchie, Lewis | |
| dc.contributor.author | Shah, Syed Ahmar | |
| dc.contributor.author | Stock, Sarah | |
| dc.contributor.author | Torabi, Fatemeh | |
| dc.contributor.author | Tsang, Ruby Sm | |
| dc.contributor.author | Wood, Rachael | |
| dc.contributor.author | Woolhouse, Mark | |
| dc.contributor.author | Robertson, Chris | |
| dc.contributor.author | Sheikh, Aziz | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2021-09-16T12:18:01Z | |
| dc.date.available | 2021-09-16T12:18:01Z | |
| dc.date.issued | 2021-05-01 | |
| dc.description | EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE—The Health Data Research Hub for Respiratory Health (MC_PC_19004), which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support has been provided through Public Health Scotland and the Scottish Government's director-general of Health and Social Care. FDRH acknowledges part support from the National Institutes of Health Research (NIHR) School for Primary Care Research, the NIHR Collaboration for Leadership in Applied Health Research and Care Oxford, and the NIHR Oxford Biomedical Research Centre. We thank Dave Kelly from Albasoft for his support with making primary care data available, and James Pickett, Wendy Inglis-Humphrey, Vicky Hammersley, Maria Georgiou, and Laura Gonzalez Rienda for their support with project management and administration. SVK acknowledges funding from an NRS Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and Scottish Government Chief Scientist Office (SPHSU13). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 717724 | |
| dc.identifier | 200471827 | |
| dc.identifier | d4a720ba-4cc5-4cff-ad1f-51760570a4e5 | |
| dc.identifier | 33901420 | |
| dc.identifier | 85104923342 | |
| dc.identifier.citation | Vasileiou, E, Simpson, C R, Shi, T, Kerr, S, Agrawal, U, Akbari, A, Bedston, S, Beggs, J, Bradley, D, Chuter, A, de Lusignan, S, Docherty, A B, Ford, D, Hobbs, F R, Joy, M, Katikireddi, S V, Marple, J, McCowan, C, McGagh, D, McMenamin, J, Moore, E, Murray, J L, Pan, J, Ritchie, L, Shah, S A, Stock, S, Torabi, F, Tsang, R S, Wood, R, Woolhouse, M, Robertson, C & Sheikh, A 2021, 'Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland : a national prospective cohort study', The Lancet, vol. 397, no. 10285, pp. 1646-1657. https://doi.org/10.1016/S0140-6736(21)00677-2 | en |
| dc.identifier.doi | 10.1016/S0140-6736(21)00677-2 | |
| dc.identifier.iss | 10285 | en |
| dc.identifier.issn | 0140-6736 | |
| dc.identifier.other | PubMedCentral: PMC8064669 | |
| dc.identifier.uri | https://hdl.handle.net/2164/17090 | |
| dc.identifier.vol | 397 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | The Lancet | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | SDG 9 - Industry, Innovation, and Infrastructure | en |
| dc.subject | Adolescent | en |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Aged, 80 and over | en |
| dc.subject | COVID-19/epidemiology | en |
| dc.subject | COVID-19 Vaccines | en |
| dc.subject | Female | en |
| dc.subject | Hospitalization/statistics & numerical data | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Mass Vaccination | en |
| dc.subject | Middle Aged | en |
| dc.subject | Pandemics/prevention & control | en |
| dc.subject | Prospective Studies | en |
| dc.subject | Risk Factors | en |
| dc.subject | Scotland/epidemiology | en |
| dc.subject | Social Class | en |
| dc.subject | Young Adult | en |
| dc.subject | R Medicine | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject | Medical Research Council (MRC) | en |
| dc.subject | MR/R008345/1 | en |
| dc.subject.lcc | R | en |
| dc.title | Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland : a national prospective cohort study | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Vasileiou_etal_Lancet_Interim_Findings_FirstDose_VOR.pdf
- Size:
- 700.9 KB
- Format:
- Adobe Portable Document Format
